Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.
The Cool Down on MSN10h
Scientists are making headway in gene editing to unlock critical potential within trees: 'These findings ... lay the groundwork for further innovations'Scientists and engineers at North Carolina State University have discovered trees can be used to produce greener, ...
Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...
StitchR, a new gene therapy technique, delivers large genes in two parts to treat muscular dystrophies by restoring critical proteins in animal models.
By employing gene-editing techniques, researchers at Pivot Bio developed microbes that remain active in high-nitrogen conditions. The study introduces PROVEN® 40, Pivot Bio’s latest product featuring ...
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...
Using CRISPR, the popular gene-editing tool, scientists bumped up the fruit’s sugar content by 30 percent without sacrificing ...
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
That, however, might be about to change. A new study published in Nature reveals that targeted gene editing can significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback